Back to Search Start Over

Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke.

Authors :
Sloane, Kelly L.
Fabian, Rachel
Wright, Amy
Saxena, Sadhvi
Kim, Kevin
Stein, Colin M.
Keser, Zafer
Glenn, Shenly
Hillis, Argye E.
Source :
Dementia & Geriatric Cognitive Disorders; 2023, Vol. 52 Issue 2, p74-82, 9p
Publication Year :
2023

Abstract

Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments would be clinically valuable if they can detect and classify cognitive deficits as effectively as traditional in-person neuropsychological testing. Methods: We tested whether the Miro application, a tablet-based neurocognitive platform, measured the same cognitive domains as traditional pencil-and-paper neuropsychological tests. Seventy-nine patients were recruited and then randomized to either undergo pencil-and-paper or tablet testing first. Twenty-nine age-matched healthy controls completed the tablet-based assessments. We identified Pearson correlations between Miro tablet-based modules and corresponding neuropsychological tests in patients and compared scores of patients with neurological disorders with those of healthy controls using t tests. Results: Statistically significant Pearson correlations between the neuropsychological tests and their tablet equivalents were found for all domains with moderate (r > 0.3) or strong (r > 0.7) correlations in 16 of 17 tests (p < 0.05). All tablet-based subtests differentiated healthy controls from neurologically impaired patients by t tests except for the spatial span forward and finger tapping modules. Participants reported enjoyment of the tablet-based testing, denied that it provoked anxiety, and noted no preference between modalities. Conclusions: This tablet-based application was found to be widely acceptable to participants. This study supports the validity of these tablet-based assessments in the differentiation of healthy controls from patients with neurocognitive deficits in a variety of cognitive domains and across multiple neurological disease etiologies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14208008
Volume :
52
Issue :
2
Database :
Complementary Index
Journal :
Dementia & Geriatric Cognitive Disorders
Publication Type :
Academic Journal
Accession number :
164344034
Full Text :
https://doi.org/10.1159/000527060